Article - 18/01/2016 New approaches in the life sciences industry: innovative strategies for courageous companies For many years, the pharmaceutical industry has been investing increasing amounts of money in the development of new products. Dr. Friedemann Taut, a specialist in anaesthesia, intensive care, emergency medicine and clinical pharmacology as well as founder and managing director of Taut Science & Service Ltd. a consultanca for Medical Device and Drug Development, explains in the following interview why small- and mid-sized companies can stay a…https:////www.gesundheitsindustrie-bw.de/en/article/news/new-avenues-in-the-life-sciences-industry-innovative-strategies-for-brave-companies
Article - 22/11/2016 Research on the durability and longevity of artificial joints In Germany alone, several hundred thousand patients are given an artificial hip, knee or shoulder joint every year. Prof. Dr. Jan Philippe Kretzer and his team of researchers in the Laboratory of Biomechanics and Implant Research at the University Hospital in Heidelberg are studying what limits the longevity of implants and how durability can be improved. https:////www.gesundheitsindustrie-bw.de/en/article/news/research-on-the-durability-and-longevity-of-artificial-joints
Article - 06/06/2018 Robots for assisting with care and treatment in nursing homes and hospitals Robotic systems have great potential in the healthcare sector. For example, intelligent care aids, such as robotic technologies, extended care trolleys and lifters make life easier for nursing home and hospital staff. Mobile robots that assist with transport tasks or guiding people can help patients become more independent.https:////www.gesundheitsindustrie-bw.de/en/article/news/robots-for-assisting-with-care-and-treatment-in-nursing-homes-and-hospitals
Article - 11/02/2010 Johanna Schanz: Liver model as an alternative to animal experiments Blood vessels of a piece of pig’s intestine are used as carrier material for the IGB’s liver model and the cells seeded on the blood vessels stem from human biopsies. Dr. Johanna Schanz from the Fraunhofer IGB used this combination to produce her doctoral thesis which led to impressive results: a functional system of blood vessels in a biological carrier structure. Schanz’s outstanding thesis results have led to the creation of a liver model for…https:////www.gesundheitsindustrie-bw.de/en/article/news/johanna-schanz-liver-model-as-an-alternative-to-animal-experiments
Industry report 2018 - 27/09/2018 The healthcare industry – the innovation driver of the 21st century: opportunities and challenges BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English. The topic neatly dovetails with the state’s political activities. An evaluation of the region carried out on behalf of the Baden-Württemberg government has clearly recognised the importance of the healthcare sector as a driver of innovation.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/the-healthcare-industry-the-innovation-driver-of-the-21st-century
Article - 10/10/2011 Meet & Match in the BioValley – bringing together international partners Small life sciences companies find it particularly difficult to set aside time for making international contacts at trade fairs. The BioValley cluster located in a region bordered by Germany France and Switzerland has a team of scouts that focus on matchmaking. Dr. Mona Boy is the coordinator of the trinational matchmaking team of the BioValley cluster.https:////www.gesundheitsindustrie-bw.de/en/article/news/meet-match-in-the-biovalley-bringing-together-international-partners
Article - 08/12/2009 Karl Stock helps turn ideas into products Karl Stock takes abstract ideas and turns them into useable technological possibilities. The 44-year-old works in what could best be described as the one-man engineering office at the Ulm-based Institute of Laser Technologies in Medicine and Metrology (ILM). In contrast to university institutes, Stock’s work does not simply finish with a “paper” published in a journal. Stock strives to go further and his real work starts where others often stop,…https:////www.gesundheitsindustrie-bw.de/en/article/news/karl-stock-helps-turn-ideas-into-products
Press release - 22/03/2011 Bringing artifical vision clinical trials to US Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States. Wills Eye to be the Primary Investigation Site to Offer the Subretinal Approach to Retinitis Pigmentosa Patients.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/bringing-artifical-vision-clinical-trials-to-us
Press release - 05/04/2011 HARTMANN continues its success Profitability improved despite difficult market conditions: In fiscal year 2010, HARTMANN continued its profitable growth despite unfavorable market conditions, building on its strong sales performance in the previous year. The company was confronted with increasing budget restrictions in the health systems and substantially higher raw material and logistics costs. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/hartmann-continues-its-success
Press release - 11/10/2012 Novalung GmbH receives EU grant for the development of a cell-coated artificial lung The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/novalung-gmbh-receives-eu-grant-for-the-development-of-a-cell-coated-artificial-lung
Article - 23/03/2017 CeMIT – professional innovation management for the medical device sector With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…https:////www.gesundheitsindustrie-bw.de/en/article/news/cemit-professional-innovation-management-for-the-medical-device-sector
Article - 16/11/2008 Limited revenue losses Despite the worldwide financial crisis the majority of German medical device manufacturers do not anticipate high revenue losses up until the end of 2009. The medical technology association SPECTARIS anticipates a revenue increase of around 5 to 18.2 billion euros for 2008 and a growth of 2- 3 for 2009.https:////www.gesundheitsindustrie-bw.de/en/article/news/limited-revenue-losses
Press release - 23/06/2016 CorTec plans to enter clinical studies with series B financing CorTec just closed a new investment that will support bringing new personalized therapies for neurological diseases to patients. With Mangold Invest a new investor could be attracted who wants to go along that way with the young medical engineering company located in Freiburg. Equally convinced of the success of this project are the previous investors who are participating in this round of financing.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cortec-plant-mit-dritter-finanzierungsrunde-den-eintritt-in-klinische-studien
Article - 22/10/2012 syneed imaging: precise visualisation of functional tissue properties Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of…https:////www.gesundheitsindustrie-bw.de/en/article/news/syneed-imaging-precise-visualisation-of-functional-tissue-properties
Press release - 09/01/2012 EU: "Virtual liver" technology helps detect liver tumours Scientists and surgeons from France, Germany, United Kingdom and Switzerland have developed a "virtual liver", using EU research funding, which will help surgeons better plan and carry out tumour operations and ensure quicker patient recovery. The PASSPORT project (Patient-Specific Simulation and Pre-Operative Realistic Training) makes a uniquely accurate "virtual liver" available to physicians based on medical images sent by…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/eu-virtual-liver-technology-helps-detect-liver-tumours
Article - 20/02/2012 Vektor-Pharma: a start-up that merges pharmacy and mechanical engineering The company Vektor-Pharma plans to develop and manufacture medicated adhesive patches and therapeutic films. Pharmacists and mechanical engineers have entered into a kind of symbiotic relationship and are currently working on the establishment of a successful business. Interdisciplinary synergy is key to developing such transdermal therapeutic systems TTS more quickly effectively and cheaply than any one discipline would be able to do on its own.…https:////www.gesundheitsindustrie-bw.de/en/article/news/vektor-pharma-a-start-up-that-merges-pharmacy-and-mechanical-engineering
Article - 16/12/2015 Small and handy – tiny LED lights can improve eye surgeons’ work A new lighting system for vitreoretinal surgery that uses small white light-emitting diode (LED) technology, promises to be safer for patients and more practical for surgeons. It will probably be three years before the idea is launched as a medical product. Prototypes need to be optimised, approved and then tested for safety and functionality at the University Eye Hospital in Frankfurt. https:////www.gesundheitsindustrie-bw.de/en/article/news/small-and-handy-tiny-led-lights-can-improve-eye-surgeons-work
Press release - 28/02/2011 Mechanical engineering meets medical engineering: implant research ‘made in Stuttgart’ Engineers from the University of Stuttgart have initiated a project on the Development and optimisation of bioactive and bioresorbable ceramic layers on implants designed to investigate implants that are more durable better tolerated by users and cheaper than those that are currently on the market. The winners of the Idea Competition in Biotechnology and Medical Technology have now been announced and an expert jury has selected the Stuttgart…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/mechanical-engineering-meets-medical-engineering-implant-research-made-in-stuttgart
Press release - 11/08/2008 Tuttlingen gets an university campus Starting in the winter semester 20092010 the new Tuttlingen University Campus of Furtwangen University of Applied Sciences will offer 35 university places each in medical technologymedical engineeringproduction engineering and mechatronics.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/tuttlingen-gets-an-university-campus
Article - 31/03/2017 Bosch to enter the medical technology sector – start-up culture meets proven expertise Many of us have known the Bosch Group mainly as a technology company that is active in the automotive sector. Now, the multinational company is opening up a whole new field of business and is entering the medical technology market with a new subsidiary. Bosch Healthcare Solutions GmbH, which is headquartered in the city of Waiblingen, has developed an innovative breath analysis device that allows asthmatics to measure the severity of airway…https:////www.gesundheitsindustrie-bw.de/en/article/news/bosch-to-enter-the-medical-technology-sector-start-up-culture-meets-proven-expertise
The Baden-Württemberg healthcare industry At a glance The Baden-Württemberg healthcare industry – a recession-proof employer that has strong ties with the region - is of key importance for the state. It comprises the biotechnology and medical technology sectors and the pharmaceutical industry. In 2018, the industry with 95,750 employees generated revenues of over 25 billion euros.https:////www.gesundheitsindustrie-bw.de:443/en/location/facts
Press release - 19/10/2010 “Regenerative medicine has the potential to revolutionise medicine” More than 300 researchers from all over the world have gathered at the Haus der Wirtschaft in Stuttgart for the 4th Congress on Regenerative Biology and Medicine BioStar 2010. In this innovative field methods and therapies are developed whereby the bodys own regenerative processes are directly supported by cell biology tissue engineering and medical technology. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/regenerative-medicine-has-the-potential-to-revolutionise-medicine
Anniversary - 12/12/2018 15 years of BIOPRO: Pooling competencies – pushing innovations This is the leitmotif of BIOPRO Baden-Württemberg GmbH, which was founded in 2003. 15 years is a good time to pause for a moment and take a look at BIOPRO’s work and achievements. As a central point of contact and wholly-owned subsidiary of the Baden-Württemberg government whose main objective is to promote networking, BIOPRO knows only too well that progress is not made alone, but in collaboration with others.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/15-years-of-biopro-pooling-competencies-pushing-innovations
Press release - 25/01/2010 Amedrix GmbH - New investment paves the way for own production operations The High-Tech Gründerfonds (HTGF) and Life Science Fonds Esslingen are jointly investing a total of 700,000 EUR in Amedrix GmbH, which was founded in January 2009. The Esslingen-based company develops innovative, acellular medical products based on animal collagen for wound regeneration and the reconstruction of degenerated soft tissue, for example. The new investment means that necessary steps can be taken to gain approval for first medical…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-new-investment-paves-the-way-for-own-production-operations
Article - 05/04/2009 JOTEC – artificial blood vessel specialist JOTEC GmbH a medical device company based in Hechingen has a broad range of solutions on offer for the therapy of vascular diseases including artificial blood vessels and stentgrafts and is an international leader in this field. The company not only produces traditional vascular grafts from high-quality plastics but also absorbable bioartificial vascular grafts and cell-coated grafts made from biomaterials. Such an approach is currently unique in…https:////www.gesundheitsindustrie-bw.de/en/article/news/jotec-artificial-blood-vessel-specialist